Shengchun Liu (S Liu)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 26

Top Topics

Epithelial Mesenchymal Transition

Transforming Growth Factor

Breast Cancer Cells

Genome Wide Analysis

Top Venues

Journal of personalized medicine

Cell death & disease

Journal of oncology

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Kang Li, Dan Shu, Han Li, Ailin Lan, Wenjie Zhang, Zhaofu Tan, Man Huang, Maria Lauda Tomasi, Aishun Jin, Haochen Yu, Meiying Shen, Shengchun Liu
SMAD4 depletion contributes to endocrine resistance by integrating ER and ERBB signaling in HR + HER2- breast cancer. Cell death & disease 15 (6) (2024)
Kang Li, Dan Shu, Han Li, Ailin Lan, Wenjie Zhang, Zhaofu Tan, Man Huang, Maria Lauda Tomasi, Aishun Jin, Haochen Yu, Meiying Shen, Shengchun Liu
SMAD4 depletion contributes to endocrine resistance by integrating ER and ERBB signaling in HR + HER2- breast cancer. Cell death & disease 15 (6) (2024)
Kang Li, Dan Shu, Han Li, Ailin Lan, Wenjie Zhang, Zhaofu Tan, Man Huang, Maria Lauda Tomasi, Aishun Jin, Haochen Yu, Meiying Shen, Shengchun Liu
SMAD4 depletion contributes to endocrine resistance by integrating ER and ERBB signaling in HR + HER2- breast cancer. Cell death & disease 15 (6) (2024)
Kang Li, Dan Shu, Han Li, Ailin Lan, Wenjie Zhang, Zhaofu Tan, Man Huang, Maria Lauda Tomasi, Aishun Jin, Haochen Yu, Meiying Shen, Shengchun Liu
SMAD4 depletion contributes to endocrine resistance by integrating ER and ERBB signaling in HR + HER2- breast cancer. Cell death & disease 15 (6) (2024)
Shun Gao, Yuan Wang, Yingkun Xu, Shengchun Liu
An Angiogenesis-Related lncRNA Signature Is Associated with Prognosis and Tumor Immune Microenvironment in Breast Cancer. Journal of personalized medicine 13 (3) (2023)
Ailin Lan, Han Li, Junru Chen, Meiying Shen, Yudi Jin, Yuran Dai, Linshan Jiang, Xin Dai, Yang Peng, Shengchun Liu
Nomograms for Predicting Disease-Free Survival Based on Core Needle Biopsy and Surgical Specimens in Female Breast Cancer Patients with Non-Pathological Complete Response to Neoadjuvant Chemotherapy. Journal of personalized medicine 13 (2) (2023)
Ailin Lan, Han Li, Junru Chen, Meiying Shen, Yudi Jin, Yuran Dai, Linshan Jiang, Xin Dai, Yang Peng, Shengchun Liu
Nomograms for Predicting Disease-Free Survival Based on Core Needle Biopsy and Surgical Specimens in Female Breast Cancer Patients with Non-Pathological Complete Response to Neoadjuvant Chemotherapy. Journal of personalized medicine 13 (2) (2023)
Shun Gao, Yuan Wang, Yingkun Xu, Shengchun Liu
An Angiogenesis-Related lncRNA Signature Is Associated with Prognosis and Tumor Immune Microenvironment in Breast Cancer. Journal of personalized medicine 13 (3) (2023)
Ailin Lan, Han Li, Junru Chen, Meiying Shen, Yudi Jin, Yuran Dai, Linshan Jiang, Xin Dai, Yang Peng, Shengchun Liu
Nomograms for Predicting Disease-Free Survival Based on Core Needle Biopsy and Surgical Specimens in Female Breast Cancer Patients with Non-Pathological Complete Response to Neoadjuvant Chemotherapy. Journal of personalized medicine 13 (2) (2023)
Shun Gao, Yuan Wang, Yingkun Xu, Shengchun Liu
An Angiogenesis-Related lncRNA Signature Is Associated with Prognosis and Tumor Immune Microenvironment in Breast Cancer. Journal of personalized medicine 13 (3) (2023)
Ailin Lan, Han Li, Junru Chen, Meiying Shen, Yudi Jin, Yuran Dai, Linshan Jiang, Xin Dai, Yang Peng, Shengchun Liu
Nomograms for Predicting Disease-Free Survival Based on Core Needle Biopsy and Surgical Specimens in Female Breast Cancer Patients with Non-Pathological Complete Response to Neoadjuvant Chemotherapy. Journal of personalized medicine 13 (2) (2023)
Yuan Wang, Shun Gao, Yingkun Xu, Zhenrong Tang, Shengchun Liu
Characterization of starvation response-related genes for predicting prognosis in breast cancer. Cancer science (2023)
Yingkun Xu, Yudi Jin, Shun Gao, Yuan Wang, Chi Qu, Yinan Wu, Nan Ding, Yuran Dai, Linshan Jiang, Shengchun Liu
Prognostic Signature and Therapeutic Value Based on Membrane Lipid Biosynthesis-Related Genes in Breast Cancer. Journal of oncology 2022 (2022)
Yingkun Xu, Han Li, Ailin Lan, Qiulin Wu, Zhenrong Tang, Dan Shu, Zhaofu Tan, Xin Liu, Yang Liu, Shengchun Liu
Cuprotosis-Related Genes: Predicting Prognosis and Immunotherapy Sensitivity in Pancreatic Cancer Patients. Journal of oncology 2022 (2022)
Zhenrong Tang, Yannan Zhao, Zaiqi Zhang, Huan Yue, Dan Wang, Shengchun Liu, Hua Tang
Study of the Antimicrobial Activity of the Chinese Dong Ethnic Minority Medicine, Madeng'ai. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Han Li, Kang Li, Dan Shu, Meiying Shen, Zhaofu Tan, Wenjie Zhang, Dongyao Pu, Wenhao Tan, Zhenrong Tang, Aishun Jin, Shengchun Liu
MED16 Promotes Tumour Progression and Tamoxifen Sensitivity by Modulating Autophagy through the mTOR Signalling Pathway in ER-Positive Breast Cancer. Life (Basel, Switzerland) 12 (10) (2022)
Ailin Lan, Yudi Jin, Yu Wang, Yihua Wang, Nan Ding, Yuran Dai, Linshan Jiang, Zhenrong Tang, Yang Peng, Shengchun Liu
Pre-treatment circulating reproductive hormones levels predict pathological and survival outcomes in breast cancer submitted to neoadjuvant chemotherapy. International journal of clinical oncology 27 (5) (2022)
Yingkun Xu, Meiying Shen, Yang Peng, Li Liu, Lingfeng Tang, Ting Yang, Dongyao Pu, Wenhao Tan, Wenjie Zhang, Shengchun Liu
Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer. BioMed research international 2022 (2022)
Yingkun Xu, Yang Peng, Meiying Shen, Li Liu, Jinwei Lei, Shun Gao, Yuan Wang, Ailin Lan, Han Li, Shengchun Liu
Construction and Validation of Angiogenesis-Related Prognostic Risk Signature to Facilitate Survival Prediction and Biomarker Excavation of Breast Cancer Patients. Journal of oncology 2022 (2022)
Yingkun Xu, Dan Shu, Meiying Shen, Qiulin Wu, Yang Peng, Li Liu, Zhenrong Tang, Shun Gao, Yuan Wang, Shengchun Liu
Development and Validation of a Novel PPAR Signaling Pathway-Related Predictive Model to Predict Prognosis in Breast Cancer. Journal of immunology research 2022 (2022)
J Lei, S Guo, K Li, J Tian, B Zong, T Ai, Y Peng, Y Zhang, Shengchun Liu
Lysophosphatidic acid receptor 6 regulated by miR-27a-3p attenuates tumor proliferation in breast cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2021)
Yihua Wang, Yu Wang, Rui Chen, Zhenrong Tang, Yang Peng, Yudi Jin, Ailin Lan, Nan Ding, Yuran Dai, Linshan Jiang, Shengchun Liu
Plasma fibrinogen acts as a predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer: a retrospective study of 1004 Chinese breast cancer patients. BMC cancer 21 (1) (2021)
Jian Xie, Yang Peng, Xiaoyu Chen, Qigang Li, Bin Jian, Zelin Wen, Shengchun Liu
LACTB mRNA expression is increased in pancreatic adenocarcinoma and high expression indicates a poor prognosis. PloS one 16 (1) (2021)
Yingzi Zhang, Jiao Tian, Chi Qu, Yang Peng, Jinwei Lei, Kang Li, Beige Zong, Lu Sun, Shengchun Liu
Overexpression of SERPINA3 promotes tumor invasion and migration, epithelial-mesenchymal-transition in triple-negative breast cancer cells. Breast cancer (Tokyo, Japan) 28 (4) (2021)
Yang Peng, Lin Shui, Jian Xie, Shengchun Liu
Development and validation of a novel 15-CpG-based signature for predicting prognosis in triple-negative breast cancer. Journal of cellular and molecular medicine 24 (16) (2020)
Yihua Wang, Yu Wang, Rui Chen, Zhenrong Tang, Shengchun Liu
A Rare Malignant Disease, Dermatofibrosarcoma Protuberans of the Breast: A Retrospective Analysis and Review of Literature. BioMed research international 2020 (2020)